Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThong, Patricia Soo-Pingen
dc.contributor.authorLee, Kijoonen
dc.contributor.authorToh, Hui-Jinen
dc.contributor.authorDong, Jingen
dc.contributor.authorTee, Chuan-Siaen
dc.contributor.authorSoo, Khee-Cheeen
dc.contributor.editorCheben, Pavelen
dc.contributor.editorSchmid, Jensen
dc.contributor.editorBoudoux, Carolineen
dc.contributor.editorDelâge, Andréen
dc.contributor.editorJanz, Siegfrieden
dc.contributor.editorKashyap, Ramanen
dc.contributor.editorLoock, Hans-Peteren
dc.contributor.editorMi, Zetianen
dc.contributor.editorChen, Lawrence R.en
dc.contributor.editorLockwood, David J.en
dc.identifier.citationThong, P. S. P., Lee, K., Toh, H.-J., Dong, J., Tee, C.-S., & Soo, K.-C. (2013). The use of diffuse optical spectroscopy and diffuse correlation spectroscopy system for monitoring of tumor response to photodynamic therapy. Proceedings of SPIE - Photonics North 2013, 8915, 891503-.en
dc.description.abstractPhotodynamic therapy (PDT) of cancer works via direct cytotoxicity, causing damage to tumor vasculature and stimulating the body’s anti-tumor immune response. PDT outcome depends on the parameters used; therefore an in vivo tumor response monitoring system is useful for optimization of the treatment protocol. The combined use of diffuse optical spectroscopy and diffuse correlation spectroscopy allows us to measure the tissue oxygen saturation (StO2) and relative blood flow (rBF) in tumors. These parameters were measured before and after PDT in mouse tumor models and were calculated as ratios relative to the baseline in each tumor (rStO2 and rBF). Readings were also measured in drugonly control tumors. In responders (mice with tumor eradication), significant PDT-induced decreases in both rStO2 and rBF levels were observed at 3h post-PDT. The rStO2 and rBF readings in these mice remained low until 48h post-PDT, with recovery of these parameters to baseline values observed 2 weeks after PDT. In non-responders (mice with partial or no response), the rStO2 and rBF levels decreased less sharply at 3h post-PDT, and the rBF values returned toward baseline values at 48h post-PDT. By comparison, the rStO2 and rBF readings in drug-only control tumors showed only fluctuations about the baseline values. Thus tumor response can be predicted as early as 3h post-PDT. Recovery or sustained decreases in rStO2 and rBF up till 48h post-PDT were correlated to long-term tumor control. Diffuse optical measurements can thus facilitate early assessment of tumor response to PDT to aid in treatment planning.en
dc.rights© 2013 Society of Photo-Optical Instrumentation Engineers (SPIE). This paper was published in Photonics North 2013 and is made available as an electronic reprint (preprint) with permission of Society of Photo-Optical Instrumentation Engineers (SPIE). The paper can be found at the following official DOI: []. One print or electronic copy may be made for personal use only. Systematic or multiple reproduction, distribution to multiple locations via electronic or other means, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper is prohibited and is subject to penalties under law.en
dc.subjectDRNTU::Engineering::Chemical engineering::Biochemical engineeringen
dc.titleThe use of diffuse optical spectroscopy and diffuse correlation spectroscopy system for monitoring of tumor response to photodynamic therapyen
dc.typeConference Paperen
dc.contributor.schoolSchool of Chemical and Biomedical Engineeringen
dc.contributor.conferencePhotonics North (2013 : Ottawa, Canada)en
dc.description.versionPublished versionen
item.fulltextWith Fulltext-
Appears in Collections:SCBE Conference Papers

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.